[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
September 9, 1998

New Drug for Erectile Dysfunction Boon for Many, "Viagravation" for Some

Author Affiliations

Not Available

Not Available

JAMA. 1998;280(10):867-869. doi:10.1001/jama.280.10.867

PSYCHIATRIC ISSUES tied to the use of oral sildenafil (Viagra) for erectile dysfunction (ED) provoked strong interest at the annual meeting of the American Psychiatric Association (APA) in Toronto, Ontario, in June. Psychiatrists' craving for information, however, went unrequited. There were no formal presentations on ED, perhaps because Viagra had been approved for sale in the United States only in March. In the meeting's commercial exhibit area, representatives of the drug's manufacturer, Pfizer Inc, New York, NY, claimed they could not answer questions because the drug was not available in Canada.

First Page Preview View Large
First page PDF preview
First page PDF preview